Listen
Listen to this article synthesis
Audio narration of the published summary.
Developing
•
Merged from 1 Canadian reporting desks.
AbCellera Biologics Inc., based in Vancouver, British Columbia, has declared the pricing details for its recently announced public offering. The company will issue 17,435,897 common shares at a price of $9.75 per share. The offering has attracted significant investor interest, leading to it being oversubscribed. In conjunction with the common shares, AbCellera is also providing pre-funded warrants that allow certain investors to purchase an additional 3,076,926 shares. This dual approach indicates strong market demand for AbCellera's equity. The funds raised will likely be directed toward advancing the company's research and development initiatives.
Analyzed Canadian Outlets (1)
1 headline
AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants
1
outlet